Induction of TGF-β and IL-10 production in dendritic cells using astilbin to inhibit dextran sulfate sodium-induced colitis

Biochemical and Biophysical Research Communications

Volumn 446, Issue 2, 2014, Pages 529-534

  Ding, Yanbing ^a   Liang, Yu ^a   Deng, Bin ^a   Qiao, Ahui ^a   Wu, Keyan ^a   Xiao, Weiming ^a   Gong, Weijuan ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Astilbin; Colitis; Dendritic cells

Indexed keywords

ASTILBIN; CD103 ANTIGEN; CD4 ANTIGEN; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COCULTURE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; UPREGULATION;

MURINAE; MUS;

ASTILBIN; COLITIS; DENDRITIC CELLS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; DENDRITIC CELLS; DEXTRAN SULFATE; FLAVONOLS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 84897974223     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.136     Document Type: Article

References (36)

1. J. Cosnes, C. Gower-Rousseau, P. Seksik, and A. Cortot Epidemiology and natural history of inflammatory bowel diseases Gastroenterology 140 2011 1785 1794
2. N.A. Molodecky, I.S. Soon, D.M. Rabi, W.A. Ghali, and M. Ferris et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 2012 46 54
3. B. Khor, A. Gardet, and R.J. Xavier Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
4. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
5. D.C. Baumgart, and W.J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 2007 1641 1657
6. C.A. Siegel, C. Hur, J.R. Korzenik, G.S. Gazelle, and B.E. Sands Risks and benefits of infliximab for the treatment of Crohn's disease Clin. Gastroenterol. Hepatol. 4 2006 1017 1024
7. W. Blonski, and G.R. Lichtenstein Safety of biologic therapy Inflamm. Bowel Dis. 13 2007 769 796
8. J.R. Kelsen, J. Kim, D. Latta, S. Smathers, and K.L. McGowan et al. Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease Inflamm. Bowel Dis. 17 2011 50 55
9. L. Beaugerie, N. Brousse, A.M. Bouvier, J.F. Colombel, and M. Lémann et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study Lancet 374 2009 1617 1625
10. A. Kandiel, A.G. Fraser, B.I. Korelitz, C. Brensinger, and J.D. Lewis Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine Gut 54 2005 1121 1125
11. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
12. + T cells J. Immunol. 184 2010 1765 1775
13. R. Kushwah, J. Wu, J.R. Oliver, G. Jiang, and J. Zhang et al. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg Eur. J. Immunol. 40 2010 1022 1035
14. S. Khan, J.D. Greenberg, and N. Bhardwaj Dendritic cells as targets for therapy in rheumatoid arthritis Nat. Rev. Rheumatol. 5 2009 566 571
15. O. Jaen, S. Rullé, N. Bessis, A. Zago, and M.C. Boissier et al. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo Immunology 126 2009 35 44
16. Q. Ouyang, and L.Y. Xue Inflammatory bowel disease in the 21(st) century in China: turning challenges into opportunities J. Dig. Dis. 13 2012 195 199
17. S. Baltatzis, F. Tufail, E.N. Yu, C.M. Vredeveld, and C.S. Foster Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders Ophthalmology 110 2003 1061 1065
18. D. Higashi, K. Seki, Y. Ishibashi, Y. Egawa, and M. Koga et al. The effect of lentinan combination therapy for unresectable advanced gastric cancer Anticancer Res. 32 2012 2365 2368
19. H. Haraguchi, Y. Mochida, S. Sakai, H. Masuda, and Y. Tamura et al. Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis Biosci. Biotechnol. Biochem. 60 1996 945 948
20. L.G. Batista Pereira, F. Petacci, J.B. Fernandes, A.G. Correa, and P.C. Vieira et al. Biological activity of astilbin from Dimorphandra mollis against Anticarsia gemmatalis and Spodoptera frugiperda Pest Manag. Sci. 58 2002 503 507
21. B. Moulari, Y. Pellequer, J.P. Chaumont, Y.C. Guillaume, and J. Millet In vitro antimicrobial activity of the leaf extract of Harungana madagascariensis Lam. Ex Poir. (Hypericaceae) against strains causing otitis externa in dogs and cats Acta Vet. Hung. 55 2007 97 105
22. B. Moulari, Y. Pellequer, H. Lboutounne, C. Girard, and J.P. Chaumont et al. Isolation and in vitro antibacterial activity of astilbin, the bioactive flavanone from the leaves of Harungana madagascariensis Lam. ex Poir. (Hypericaceae) J. Ethnopharmacol. 106 2006 272 278
23. V. Cechinel-Filho, Z.R. Vaz, L. Zunino, J.B. Calixto, and R.A. Yunes Antinociceptive and anti-oedematogenic properties of astilbin, taxifolin and some related compounds Arzneimittelforschung 50 2000 281 285
24. H. Huang, Z. Cheng, H. Shi, W. Xin, T.T. Wang, and L.L. Yu Isolation and characterization of two flavonoids, engeletin and astilbin, from the leaves of Engelhardia roxburghiana and their potential anti-inflammatory properties J. Agric. Food Chem. 59 2011 4562 4569
25. Y. Cai, T. Chen, and Q. Xu Astilbin suppresses collagen-induced arthritis via the dysfunction of lymphocytes Inflamm. Res. 52 2003 334 340
26. H.W. Yi, X.M. Lu, F. Fang, J. Wang, and Q. Xu Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF-alpha and its associated MMP-9 activity and CD44 expression Int. Immunopharmacol. 8 2008 1467 1474
27. M. Fei, X. Wu, and Q. Xu Astilbin inhibits contact hypersensitivity through negative cytokine regulation distinct from cyclosporin A J. Allergy Clin. Immunol. 116 2005 1350 1356
28. + dendritic cells: master regulators of tolerance Trends Immunol. 32 2011 412 421
29. R. Zeng, C. Oderup, and R. Yuan et al. Retinoic acid regulates the development of a gut-homing precursor for intestinal dendritic cells Mucosal Immunol. 12 2012 58 67
30. Y. Cai, T. Chen, and Q. Xu Astilbin suppresses delayed-type hypersensitivity by inhibiting lymphocyte migration J. Pharm. Pharmacol. 55 2003 691 695
31. S. Zou, X. Shen, Y. Tang, Z. Fu, Q. Zheng, and Q. Wang Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice Transplant Proc. 42 2010 3798 3802
32. S.H. Song, X.Y. Shen, G.S. Ding, F. Liu, Z.M. Wang, and Z.R. Fu Effects of astilbin on maturation and immunologic function of mouse bone marrow-derived dendritic cells Zhong Xi Yi Jie He Xue Bao 8 2010 145 151
33. A. Izcue, J.L. Coombes, and F. Powrie Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation Immunol. Rev. 212 2006 256 271
34. C. Keijzer, R. van der Zee, W. van Eden, and F. Broere Treg inducing adjuvants for therapeutic vaccination against chronic inflammatory diseases Front. Immunol. 4 2013 245
35. F. Leon, L.E. Smythies, P.D. Smith, and B.L. Kelsall Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease Adv. Exp. Med. Biol. 579 2006 117 132
36. S. Rutella, and F. Locatelli Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease World J. Gastroenterol. 17 2011 3761 3775